CNR1 and neoplasm: Using CB1/CB2-receptor deficient mice (CB1/2−/−), Glodde's group demonstrated that the anti-tumor effect of Δ9-THC on HCmel12 xenografts was dependent on cannabinoid receptors (Glodde et al., 2015).